Drug Information

Drug General Information
Drug ID
D01FCK
Former ID
DIB008002
Drug Name
Teglicar
Synonyms
Reversible palmitoyltransferase inhibitor; ST-1326
Drug Type
Small molecular drug
Indication Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] Discontinued in Phase 2 [547517]
Company
Sigma-Tau SpA
Formula
C22H45N3O3
Canonical SMILES
[C@H](NC(=O)NCCCCCCCCCCCCCC)(C[N+](C)(C)C)CC(=O)[O-]
CAS Number
CAS 250694-07-6
PubChem Compound ID
9843897
Target and Pathway
Target(s) Carnitine acyltransferase Target Info Inhibitor [544162]
References
Ref 547517Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017026)
Ref 544162Selective Reversible Inhibition of Liver Carnitine Palmitoyl-Transferase 1 by Teglicar Reduces Gluconeogenesis and Improves Glucose Homeostasis. Diabetes. 2011 February; 60(2): 644-651.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.